George Clinical Brings Robust Retention Strategy and Tactics to Global Rare Renal Disease Studies
We work to keep every patient engaged to the end, from risk retention matrix and personal contact with CRAs, to patient-facing animation in 20 languages. SITUATION Clinical trials for rare diseases pose specific challenges due to their elusive nature and low patient populations. Research is critical for these often serious and even life-threatening diseases that […]
Read More